Ifinwil (eflornithine)
Orphan
- Region
- 🇪🇺 EU
- Active substance
- eflornithine
- Company
- Norgine B.V.
- Status
- Application withdrawn
- Therapeutic area
- Neuroblastoma
- Designations
- Orphan
- Application
- EMEA/H/C/006067
- ATC
- L01XX79
- Official record
- www.ema.europa.eu
Indication
Treatment of high-risk neuroblastoma responsive to prior multiagent, multimodality therapy
Regulatory milestones
No milestones recorded in the last year.
Same substance in other markets
- 🇪🇺 Vaniqa Authorised · Almirall, S.A.
- 🇪🇺 Flynpovi Application withdrawn · Cancer Prevention Pharma (Ireland) Limited
Follow Ifinwil
Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.